Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / HEALTHCARE BUL
-
Total 13F shares
-
199,383
-
Share change
-
+57,501
-
Total reported value
-
$9,488,000
-
Put/Call ratio
-
37%
-
Price per share
-
$47.59
-
Number of holders
-
13
-
Value change
-
+$2,674,818
-
Number of buys
-
6
-
Number of sells
-
6
Institutional Holders of DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) as of Q4 2018
As of 31 Dec 2018,
DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
199,383 shares.
The largest 10 holders included
CITADEL ADVISORS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, JANE STREET GROUP, LLC, BANQUE PICTET & CIE SA, Tower Research Capital LLC (TRC), Traynor Capital Management, Inc., Capital Analysts, LLC, Virtu Financial LLC, UBS Group AG, and MORGAN STANLEY.
This page lists
13
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.